| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.3B | $1.3B | $1.2B | $1.2B | $1.3B | $1.4B | $1.5B | $1.3B |
| Cost of Revenue | — | $0.0B | $0.0B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.6B | $0.6B | $0.7B | $0.6B | $0.1B | $0.2B | $0.1B |
| EPS (Basic) | $1.13 | $3.96 | $3.81 | $4.42 | $3.19 | $2.01 | $3.22 | $2.83 |
| EPS (Diluted) | $1.12 | $3.92 | $3.77 | $4.35 | $3.16 | $0.76 | $0.79 | $0.64 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.1B | $8.7B | $7.6B | $7.1B | $7.8B | $7.9B | $6.8B | $6.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.1B | $0.2B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $3.3B | $4.0B | $3.2B | $3.1B | $3.6B | $3.7B | $2.8B | $2.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $4.8B | $4.6B | $4.4B | $3.9B | $4.3B | $4.3B | $4.0B | $3.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.1B | $-0.7B | $0.5B | $0.4B | $0.6B | $0.7B | $0.7B | — |
| Investing Cash Flow | $0.1B | $0.3B | $-0.3B | $-0.0B | $-0.0B | $-0.9B | $-0.3B | — |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.2B | $0.4B | $-0.3B | $-0.5B | $-0.5B | $0.2B | $-0.4B | — |